SCHEMBL29464255

SCHEMBL29464255

CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ PTH1R Q03431 9/20 0.55
▸ CCNA2 P20248 2/20 0.54
▸ CDK2 P24941 2/20 0.54
▸ CCNA1 P78396 2/20 0.54
▸ CCKBR P32239 1/20 0.52
▸ GLP1R P43220 1/20 0.52
▸ SLC2A1 P11166 2/20 0.51
▸ CRHR1 P34998 1/20 0.51
▸ CRHR2 Q13324 1/20 0.51
▸ OPRL1 P41146 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29350082 0.85 OPRL1 (0.61) PTH1RCCNA2CDK2CCNA1CCKBR
SCHEMBL29352003 0.84 CCNA2 (0.57) PTH1RCCNA2CDK2CCNA1OPRL1
SCHEMBL31104924 0.84 GLP1R (0.66) PTH1RCCKBRGLP1RCRHR1CRHR2
SCHEMBL31104935 0.84 GLP1R (0.70) PTH1RCCKBRGLP1RCRHR1CRHR2
SCHEMBL30640630 0.84 GLP1R (0.70) PTH1RCCKBRGLP1RCRHR1CRHR2
Magainin 2 SCHEMBL29374652 0.83 PTH1R (0.66) PTH1RCCKBRGLP1RSLC2A1
SCHEMBL29736049 0.83 CCNA2 (0.65) PTH1RCCNA2CDK2CCNA1
SCHEMBL30633102 0.83 PTH1R (0.61) PTH1RCCKBRGLP1RSLC2A1
SCHEMBL29419646 0.83 CCNA2 (0.58) PTH1RCCNA2CDK2CCNA1
SCHEMBL29389123 0.82 PTH1R (0.63) PTH1RGLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118324870-A Improved peptide drugs for insulin resistance 梅德瑞斯糖尿病有限责任公司 2024-07-12 — — CN disclosed
CN-117903257-A Improved peptide drugs for insulin resistance 梅德瑞斯糖尿病有限责任公司 2024-04-19 — — CN disclosed
CN-117582516-A Improved peptide drugs against insulin resistance 梅德瑞斯糖尿病有限责任公司 2024-02-23 — — CN disclosed
CN-117180445-A Improved peptide drugs against insulin resistance 梅德瑞斯糖尿病有限责任公司 2023-12-08 — — CN disclosed
WO-2023128419-A1 METHOD FOR SCREENING COLORECTAL CANCER AND COLORECTAL POLYPS OR ADVANCED ADENOMAS AND APPLICATION THEREOF 주식회사 이노제닉스 2023-07-06 — — WO disclosed
WO-2023128429-A1 METHOD FOR SCREENING COLORECTAL CANCER AND ADVANCED ADENOMA, AND APPLICATION THEREOF 주식회사 이노제닉스 2023-07-06 — — WO disclosed
CN-112410381-B Method for producing epsilon-polylysine and hydrochloride thereof by rapid fermentation 郑州拜纳佛生物工程股份有限公司 2022-09-30 — — CN disclosed
CN-109477839-B Method for measuring glycated albumin 旭化成制药株式会社 2022-06-14 — — CN disclosed
CN-114181388-A Method for extracting polylysine from fermentation liquor 河北圣雪大成制药有限责任公司 2022-03-15 — — CN disclosed
Send feedback